Functional Magnetic Resonance Imaging of Effects of a Nicotinic Agonist in Schizophrenia

3-(2,4-Dimethoxybenzylidene)-anabaseine (DMXB-A) is a partial agonist at α7-nicotinic acetylcholine receptors and is now in early clinical development for treatment of deficits in neurocognition and sensory gating in schizophrenia. During its initial phase 2 test, functional magnetic resonance imagi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Tregellas, Jason R, Olincy, Ann, Johnson, Lynn, Tanabe, Jody, Shatti, Shireen, Martin, Laura F, Singel, Debra, Du, Yiping P, Soti, Ferenc, Kem, William R, Freedman, Robert
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2010
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2834253/
https://ncbi.nlm.nih.gov/pubmed/19956085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2009.196
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars